Cite
HARVARD Citation
Ding, X. et al. (2020). Early Adalimumab and Anti‐Adalimumab Antibody Levels for Prediction of Primary Nonresponse in Ankylosing Spondylitis Patients. Clinical and translational science. 13 (3), pp. 547-554. [Online].
This is an interim version of our Electronic Legal Deposit Catalogue-eJournals and eBooks while we continue to recover from a cyber-attack.
Ding, X. et al. (2020). Early Adalimumab and Anti‐Adalimumab Antibody Levels for Prediction of Primary Nonresponse in Ankylosing Spondylitis Patients. Clinical and translational science. 13 (3), pp. 547-554. [Online].